Invasive candidiasis treatment rezafungin wins orphan drug status
IC is a severe and life-threatening form of Candida infection
Read More
Tag: Rezafungin
Cidara, Mundipharma team up to commercialise Rezafungin
The total transaction value could exceed $568 million.
Read More
- GSK wins US approval for ROS1 lung cancer therapy
- Lundbeck secures FDA Fast Track for narcolepsy drug
- R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
- Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million
- Nouscom to present re‑treatment data in Lynch Syndrome at ESMO 2026
